- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07842913
Hybrid Telerehabilitation for Anterior Knee Pain in Routine Physiotherapy Practice
Integrating Hybrid Telerehabilitation Into Routine Physiotherapy Practice for Anterior Knee Pain: Protocol for a Real-World Pragmatic Mixed-Methods Study
This study will examine how hybrid telerehabilitation is used in routine physiotherapy care for adults with anterior knee pain. Approximately 30 participants will be followed for 72 weeks while receiving individualized treatment from their physiotherapist, supported by the moveUP mobile application. The application provides prescribed exercises, educational information, communication with the physiotherapist, and progress monitoring.
The study will assess adherence to rehabilitation, pain, knee function, quality of life, psychological factors, and physical activity. It will also explore whether patient adherence and physiotherapist engagement are associated with clinical outcomes. Interviews with patients and healthcare professionals will examine barriers and facilitators to using the platform in routine care.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Miguel Farraj, PhD candidate
- Phone Number: +32494035113
- Email: miguel.farraj@ulb.be
Study Locations
-
-
-
Brussels, Belgium
- Recruiting
- Private clinics
-
Contact:
- Miguel Farraj, PhD candidate
- Phone Number: +32494035113
- Email: miguel.farraj@ulb.be
-
-
-
-
-
Paris, France
- Recruiting
- Private clinics
-
Contact:
- Miguel Farraj, PhD candidate
- Phone Number: +32494035113
- Email: miguel.farraj@ulb.be
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 years or older.
- Clinical diagnosis of anterior knee pain, including patellofemoral pain, patellar tendinopathy, Hoffa's fat pad syndrome, chondromalacia, or femoropatellar, tibiopatellar, or tibiofemoral osteoarthritis not requiring surgery.
- Access to a smartphone compatible with the moveUP application.
Exclusion Criteria:
- Currently awaiting spine or lower-limb surgery.
- Lower-limb surgery or other invasive intervention within the previous two years.
- Joint prosthesis.
- Acute trauma to the trunk or lower limbs, or fracture, dislocation, or other musculoskeletal pathology of the affected lower limb within the previous six months.
- Saphenous nerve neuritis or Ehlers-Danlos syndrome.
- Severe osteoarthritis requiring joint replacement, systemic inflammatory joint disease (including rheumatoid arthritis or gout), or joint infection.
- Persistent low back pain lasting three months or longer.
- Vascular, respiratory, or neurological conditions that interfere with participation.
- Cognitive or psychiatric impairment limiting application use or communication.
- Pregnancy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Hybrid Telerehabilitation
Participants receive individualized physiotherapy for anterior knee pain supported by the moveUP mobile application over 72 weeks. Treatment is prescribed and adapted by the treating physiotherapist according to individual patient needs. |
Hybrid telerehabilitation combining routine physiotherapy with the moveUP mobile application for adults with anterior knee pain. The platform supports individualized exercise prescription, educational modules, patient-physiotherapist communication, and progress monitoring. Exercise selection, frequency, and progression are determined by the treating physiotherapist according to patient needs. Participants are followed for 72 weeks. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exercise Adherence (ATEMPT Score)
Time Frame: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
Exercise adherence will be assessed using the Adherence to Exercise for Musculoskeletal Pain Tool (ATEMPT). Total scores range from 6 to 30, with higher scores indicating greater adherence. |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Pain Intensity (Visual Analog Scale)
Time Frame: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
Pain intensity will be measured using a 0-100 mm Visual Analog Scale (VAS), where 0 indicates no pain and 100 indicates the worst pain imaginable. Higher scores indicate greater pain intensity. |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knee Function (Anterior Knee Pain Scale)
Time Frame: aseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
The Anterior Knee Pain Scale assesses symptoms and functional limitations associated with anterior knee pain. The total score ranges from 0 to 100, with higher scores indicating better function and fewer symptoms |
aseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Health-Related Quality of Life (EQ-5D)
Time Frame: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire. Responses will be converted into a utility index using the Belgian value set. Scores range from -0.532 to 1, with higher scores indicating better health-related quality of life. |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Fear of Movement (Tampa Scale for Kinesiophobia)
Time Frame: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
The 11-item Tampa Scale for Kinesiophobia assesses fear of movement or reinjury. The total score ranges from 11 to 44, with higher scores indicating greater kinesiophobia and therefore a worse outcome |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Pain Catastrophizing (Pain Catastrophizing Scale)
Time Frame: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
The Pain Catastrophizing Scale is a 13-item questionnaire assessing catastrophic thoughts related to pain. The total score ranges from 0 to 52, with higher scores indicating greater pain catastrophizing and therefore a worse outcome |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Physical Activity (Daily Step Count)
Time Frame: Daily/weekly
|
Daily/weekly
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- AIM2-AKP-001
- 2024-RDIR-5c (Other Grant/Funding Number: Innoviris)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.